Labocanna

Labocanna Gross Margin

The Gross Margin of Labocanna (LCN.WA) as of Oct 18, 2026 is 17.75 %. In the previous year, Gross Margin was 20.84 % — a change of -14.84% (lower).

Gross Margin

17.75 %

YoY

-14.84%

Last updated:

Gross Margin of Labocanna is 2025 17.75 % . Gross Margin of Labocanna was 2024 20.84 % . It decreases by -14.84% lower compared to the previous year.

For Labocanna, the gross margin of 17.8% is down versus 60.6% a few years ago.

The Labocanna Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
95.08 PLN
Jan 1, 2019
88.89 PLN
Jan 1, 2020
100.00 PLN
Jan 1, 2021
60.61 PLN
Jan 1, 2022
-696.00 PLN
Jan 1, 2023
-30.66 PLN
Jan 1, 2024
20.84 PLN
Jan 1, 2025
17.75 PLN
The Labocanna Gross Margin history
YEARGross MarginYoY
17.75 %-14.84%
20.84 %-167.98%
-30.66 %-95.59%
-696.00 %-1,248.40%
60.61 %-39.39%
100.00 %+12.50%
88.89 %-6.51%
95.08 %-1.85%
96.87 %-0.86%
97.72 %+1.41%
96.35 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

Gross Margin of Labocanna is 17.75 % in 2025.

Gross Margin of Labocanna changed from 20.84 % to 17.75 %, representing a -14.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Labocanna since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Labocanna with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Labocanna

All Key Metrics — Labocanna